Pixium Vision announces its cash position at 31 March 2021 and provides an update on its activities and financial outlook until the end of 2021. - Seite 3
For more information: http://www.pixium-vision.com/fr
Follow us on @PixiumVision; www.facebook.com/pixiumvision
www.linkedin.com/company/pixium-vision
Contacts
Pixium Vision Guillaume Renondin Chief Financial Officer investors@pixium-vision.com +33 1 76 21 47 68 |
Media relations LifeSci Advisors Sophie Baumont sophie@lifesciadvisors.com +33 6 27 74 74 49 |
Investor relations LifeSci Advisors Guillaume van Renterghem gvanrenterghem@lifesciadvisors.com +41 76 735 01 31 |
1 On 3 April 2021, Pixium Vision announced that it acknowledged Second Sight Medical Products, Inc.’s unilateral termination of the memorandum of understanding entered into on 5 January 2021, which terminated the proposed business combination between the two companies.
Lesen Sie auch
Attachment
Diskutieren Sie über die enthaltenen Werte
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte